Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex
Journal of Medicinal Chemistry · 23.05.2024 · 67 (10) · 7911-7920
DOI: 10.1021/acs.jmedchem.3c02018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.05.2024. Verfasst von Siyu Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Materials Science, Fujian Provincial Key Laboratory of Advanced Materials Oriented Chemical Engineering, Fujian Normal Unive…. Hauptthemen laut MEDLINE: Copper, Mitochondria, Antineoplastic Agents, Reactive Oxygen Species. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Using copper-ionophores to translocate extracellular copper into mitochondria is a clinically validated anticancer strategy that has been identified as a new type of regulated cell death termed "cuproptosis." This study reports a mitochondria-targeting Cu(I) complex, Cu(I)Br(PPh3)3 (CBP), consisting of a cuprous ion coordinated by three triphenylphosphine moieties and a Br atom. CBP exhibited antitumor and antimetastatic efficacy in vitro and in vivo by specifically targeting mitochondria instigating mitochondrial dysfunction. The cytotoxicity of CBP could only be reversed by a copper chelator rather than inhibitors of the known cell death, indicating copper-dependent cytotoxicity. Furthermore, CBP induced the oligomerization of lipoylated proteins and the loss of Fe-S cluster proteins, consistent with characteristic features of cuproptosis. Additionally, CBP induced remarkable intracellular generation of reactive oxygen species (ROS) through a Fenton-like reaction, indicating a complex antitumor mechanism. This is a proof-of-concept study exploiting the antitumor activity and mechanism of the Cu(I)-based mitochondria-targeting therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Materials Science, Fujian Provincial Key Laboratory of Advanced Materials Oriented Chemical Engineering, Fujian Normal University, 32 Shangsan Road, Fuzhou 350007, P. R. China.
- College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian 350108, P. R. China.
- College of Chemistry, Fuzhou University, Fuzhou, Fujian 350108, P. R. China.
ORCID-Profile: Mingdong Huang, Ke-Zhao Du, Peng Xu
Förderung
- Natural Science Foundation of Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Xu, S., Hao, Y., Xu, X., Huang, L., Liang, Y., Liao, J., Yang, J. R., Zhou, Y., Huang, M., Du, K. Z., Zhang, C., & Xu, P. (2024). Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex. Journal of Medicinal Chemistry, 67(10), 7911-7920. https://doi.org/10.1021/acs.jmedchem.3c02018
Vancouver
Xu S, Hao Y, Xu X, Huang L, Liang Y, Liao J, et al. Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex. Journal of Medicinal Chemistry. 2024;67(10):7911-7920. doi:10.1021/acs.jmedchem.3c02018
BibTeX
@article{Xu2024,
author = {Xu, Siyu and Hao, Yashuai and Xu, Xinyi and Huang, Lu and Liang, Yuqiong and Liao, Jia and Yang, Jie-Ru and Zhou, Yang and Huang, Mingdong and Du, Ke-Zhao and Zhang, Cen and Xu, Peng},
title = {Antitumor Activity and Mechanistic Insights of a Mitochondria-Targeting Cu(I) Complex},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {10},
pages = {7911--7920},
doi = {10.1021/acs.jmedchem.3c02018}
}
EUVIMED